Through modifying PHLPP2 and FOXO4, miR-762 expression may stimulate the AKT signalling pathway in head and neck squamous cell carcinoma and promote migration, proliferation, and EMT17. Here, PHLPP2 is linked to head and neck squamous cell carcinoma.